Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Recro Pharma, Inc. - Common Stock
(NQ:
REPH
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
1.600 (2)
Ask (Size)
2.300 (3)
Prev. Close
2.090
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
90,127,280
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Recro Pharma Earnings Perspective: Return On Capital Employed
↗
March 07, 2022
According to data from Benzinga Pro, during Q4, Recro Pharma's (NASDAQ:REPH) reported sales totaled $22.30 million. Despite a 32.39% increase in earnings, the company posted a...
Via
Benzinga
Recap: Recro Pharma Q4 Earnings
↗
March 01, 2022
Recro Pharma (NASDAQ:REPH) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Recro...
Via
Benzinga
Performance
More News
Read More
Earnings Scheduled For March 1, 2022
↗
March 01, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
January 12, 2022
Via
Benzinga
5 Penny Stocks Insiders Are Buying
↗
November 16, 2021
Via
Benzinga
Recro Secures Manufacturing Contract From NIH For Nasal Spray Analgesic
↗
October 20, 2021
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Via
Benzinga
Earnings Scheduled For May 6, 2021
↗
May 06, 2021
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
↗
November 09, 2021
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2021
↗
October 12, 2021
Via
Benzinga
Recro Pharma's Return On Capital Employed Overview
↗
September 16, 2021
Via
Benzinga
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
September 08, 2021
Via
NewMediaWire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 01, 2021
Via
Benzinga
60 Biggest Movers From Yesterday
↗
August 17, 2021
Via
Benzinga
38 Stocks Moving In Monday's Mid-Day Session
↗
August 16, 2021
Via
Benzinga
78 Biggest Movers From Friday
↗
August 16, 2021
Via
Benzinga
Recro Pharma: Q2 Earnings Insights
↗
August 09, 2021
Via
Benzinga
Earnings Scheduled For August 9, 2021
↗
August 09, 2021
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 12, 2021
Via
Benzinga
70 Biggest Movers From Friday
↗
May 10, 2021
Via
Benzinga
56 Stocks Moving In Friday's Mid-Day Session
↗
May 07, 2021
Via
Benzinga
Earnings Preview for Recro Pharma
↗
May 05, 2021
Via
Benzinga
Frequently Asked Questions
Is Recro Pharma, Inc. - Common Stock publicly traded?
Yes, Recro Pharma, Inc. - Common Stock is publicly traded.
What exchange does Recro Pharma, Inc. - Common Stock trade on?
Recro Pharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Recro Pharma, Inc. - Common Stock?
The ticker symbol for Recro Pharma, Inc. - Common Stock is REPH on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.